V. Grdzelishvili

发表

Systematic, genome-wide identification of host genes affecting replication of a positive-strand RNA virus

P. Ahlquist, B. Lindenbach, D. Kushner, 2003, Proceedings of the National Academy of Sciences of the United States of America.

An unexpected inhibition of antiviral signaling by virus-encoded tumor suppressor p53 in pancreatic cancer cells.

V. Grdzelishvili, Eric Hastie, M. Cataldi, 2015, Virology.

Cell Type Mediated Resistance of Vesicular Stomatitis Virus and Sendai Virus to Ribavirin

Nirav R. Shah, V. Grdzelishvili, Amanda Sunderland, 2010, PloS one.

Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions

V. Grdzelishvili, Molly Holbrook, Dakota W. Goad, 2021, Cancers.

Ruxolitinib and Polycation Combination Treatment Overcomes Multiple Mechanisms of Resistance of Pancreatic Cancer Cells to Oncolytic Vesicular Stomatitis Virus

V. Grdzelishvili, S. Felt, Gaith N. Droby, 2017, Journal of Virology.

Characterization of retinoic acid—inducible gene-I expression in primary murine glia following exposure to vesicular stomatitis virus

V. Grdzelishvili, I. Marriott, V. Chauhan, 2011, Journal of NeuroVirology.

Cell Cycle Arrest in G2/M Phase Enhances Replication of Interferon-Sensitive Cytoplasmic RNA Viruses via Inhibition of Antiviral Gene Expression

V. Grdzelishvili, N. Steuerwald, Gaith N. Droby, 2018, Journal of Virology.

Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer.

V. Grdzelishvili, Eric Hastie, 2012, The Journal of general virology.

The Use of a Novel MUC 1 Antibody to Identify Cancer Stem Cells and Circulating MUC 1 in Mice and Patients With Pancreatic Cancer

V. Grdzelishvili, D. Sindram, I. McKillop, 2013 .

The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer

V. Grdzelishvili, D. Sindram, I. McKillop, 2013, Journal of surgical oncology.

Acquired chemoresistance can lead to increased resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus

V. Grdzelishvili, Molly Holbrook, Dakota W. Goad, 2021, Molecular therapy oncolytics.

RIG‐I mediates nonsegmented negative‐sense RNA virus‐induced inflammatory immune responses of primary human astrocytes

V. Grdzelishvili, I. Marriott, Samantha R. Furr, 2010, Glia.

Vesicular stomatitis virus infects resident cells of the central nervous system and induces replication-dependent in fl ammatory responses

V. Grdzelishvili, I. Marriott, V. Chauhan, 2010 .

Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update.

V. Grdzelishvili, S. Felt, 2017, The Journal of general virology.

Breaking resistance of pancreatic cancer cells to an attenuated vesicular stomatitis virus through a novel activity of IKK inhibitor TPCA-1.

Nirav R. Shah, V. Grdzelishvili, M. Cataldi, 2015, Virology.

A Single Amino Acid Change in the L-Polymerase Protein of Vesicular Stomatitis Virus Completely Abolishes Viral mRNA Cap Methylation

V. Grdzelishvili, R. Hall, S. Moyer, 2005, Journal of Virology.

mRNA Cap Methylation Stomatitis Virus Completely Abolishes Viral L-Polymerase Protein of Vesicular A Single Amino Acid Change in the

V. Grdzelishvili, R. Hall, S. Moyer, 2005 .

Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: role of type I interferon signaling.

Nirav R. Shah, V. Grdzelishvili, Eric Hastie, 2013, Virology.

Vesicular Stomatitis Virus as an Oncolytic Agent against Pancreatic Ductal Adenocarcinoma

V. Grdzelishvili, P. Mukherjee, D. Ornelles, 2013, Journal of Virology.

ONCOLYTIC VESICULAR STOMATITIS VIRUS IN IMMUNOCOMPETENT MODEL OF 1 MUC 1 POSITIVE AND MUC 1 NULL PANCREATIC DUCTAL ADENOCARCINOMA 2 3 Running Title : “ VSV IN AN IMMUNOCOMPETENT MODEL OF PANCREATIC 4 CANCER ”

Nirav R. Shah, V. Grdzelishvili, Eric Hastie, 2013 .

Movement of hordeivirus hybrids with exchanges in the triple gene block.

V. Grdzelishvili, J. Schiemann, E. Savenkov, 1999, Virology.

Movement of a barley stripe mosaic virus chimera with a tobacco mosaic virus movement protein.

V. Grdzelishvili, E. Savenkov, S. Morozov, 1996, Virology.

Cellular Proteins Associated with the Interior and Exterior of Vesicular Stomatitis Virus Virions

V. Grdzelishvili, M. Moerdyk-Schauwecker, Sun-il Hwang, 2014, PloS one.

Identification of a new region in the vesicular stomatitis virus L polymerase protein which is essential for mRNA cap methylation.

V. Grdzelishvili, R. Hall, S. Moyer, 2006, Virology.

Oncolytic Vesicular Stomatitis Virus in an Immunocompetent Model of MUC1-Positive or MUC1-Null Pancreatic Ductal Adenocarcinoma

Nirav R. Shah, V. Grdzelishvili, Eric Hastie, 2013, Journal of Virology.

Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene Therapy

V. Grdzelishvili, Eric Hastie, C. Bressy, 2017, Molecular therapy oncolytics.

Experimental Evolution Generates Novel Oncolytic Vesicular Stomatitis Viruses with Improved Replication in Virus-Resistant Pancreatic Cancer Cells

V. Grdzelishvili, I. Nesmelova, Sarah Greene, 2019, Journal of Virology.

Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus

V. Grdzelishvili, Eric Hastie, M. Cataldi, 2016, Oncotarget.

Mapping of the Tobacco mosaic virus movement protein and coat protein subgenomic RNA promoters in vivo.

D. J. Lewandowski, V. Grdzelishvili, S. Chapman, 2000, Virology.

Induction of apoptosis in pancreatic cancer cells by vesicular stomatitis virus.

V. Grdzelishvili, M. Moerdyk-Schauwecker, S. Felt, 2015, Virology.

Mutual Interference between Genomic RNA Replication and Subgenomic mRNA Transcription in Brome Mosaic Virus

Tokiko Watanabe, P. Ahlquist, V. Grdzelishvili, 2005, Journal of Virology.

Analysis of virion associated host proteins in vesicular stomatitis virus using a proteomics approach

V. Grdzelishvili, M. Moerdyk-Schauwecker, Sun-il Hwang, 2009, Virology Journal.

Sequence–function analysis of the Sendai virus L protein domain VI

A. Mushegian, V. Grdzelishvili, M. Moerdyk-Schauwecker, 2010, Virology.

Vesicular stomatitis virus infects resident cells of the central nervous system and induces replication-dependent inflammatory responses.

V. Grdzelishvili, I. Marriott, V. Chauhan, 2010, Virology.

Understanding and altering cell tropism of vesicular stomatitis virus.

V. Grdzelishvili, Eric Hastie, M. Cataldi, 2013, Virus research.

Detecting protein-protein interactions in vesicular stomatitis virus using a cytoplasmic yeast two hybrid system.

V. Grdzelishvili, Eric Hastie, M. Moerdyk-Schauwecker, 2011, Journal of virological methods.

Identification of Sendai Virus L Protein Amino Acid Residues Affecting Viral mRNA Cap Methylation

V. Grdzelishvili, Andrea M. Murphy, 2008, Journal of Virology.

etecting protein – protein interactions in vesicular stomatitis virus using a ytoplasmic yeast two hybrid system

V. Grdzelishvili, Eric Hastie, D. Destephanis, 2011 .

Identiﬁcation of Sendai Virus L Protein Amino Acid Residues Affecting Viral mRNA Cap Methylation (cid:1)

V. Grdzelishvili, Andrea M. Murphy, 2009 .

Host-controlled cell-to-cell movement of a hybrid barley stripe mosaic virus expressing a dianthovirus movement protein.

V. Grdzelishvili, E. Savenkov, E. Maiss, 1997, Intervirology.

Evolution of oncolytic viruses.

R. Sanjuán, V. Grdzelishvili, 2015, Current opinion in virology.

Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: role of type I interferon signaling.

Nirav R. Shah, V. Grdzelishvili, Eric Hastie, 2013, Virology.

Vesicular Stomatitis Virus as an Oncolytic Agent against Pancreatic Ductal Adenocarcinoma

V. Grdzelishvili, P. Mukherjee, D. Ornelles, 2012, Journal of Virology.

Intertumoral heterogeneity impacts oncolytic vesicular stomatitis virus efficacy in mouse pancreatic cancer cells

V. Grdzelishvili, Laurel R. Yohe, D. W. Goad, 2023, Journal of virology.